<link rel='stylesheet' href='https//fonts.googleapis.com/css?family=Roboto:400,500,700,400italic|Material+Icons'>
Open Search
OCX
OncoCyte
$
()


  • Biotech Alert: Searches spiking for these stocks today

    4/15/2024 - 10:45am
  • Fly Intel: Pre-market Movers

    4/12/2024 - 08:55am
  • OncoCyte reports Q4 revenue $314,000, consensus $320,000

    4/12/2024 - 06:06am
  • OncoCyte to sell 5.077M shares at $ 2.92 in private placement

    4/12/2024 - 05:11am
  • Fly Intel: After-Hours Movers

    4/11/2024 - 18:23pm
  • OncoCyte, BioRad to partner on global launch of GraftAssure assay

    4/11/2024 - 17:31pm
  • Two new option listings and option delistings on February 26th

    2/26/2024 - 08:30am
  • Biotech Alert: Searches spiking for these stocks today

    1/5/2024 - 11:01am
  • OncoCyte begins FDA submissions process for VitaGraft transplant assays

    12/6/2023 - 08:06am
  • OncoCyte reports Q3 EPS (81c), consensus ($1.01)

    11/9/2023 - 07:04am
  • OncoCyte presents clinical data on VitaGraft Kidney

    9/18/2023 - 08:25am
  • OncoCyte's VitaGraft Kidney test receives CMS coverage

    8/28/2023 - 08:53am
  • OncoCyte price target lowered to $5 from $9 at Benchmark

    8/24/2023 - 07:16am
  • OncoCyte price target lowered to $3.50 from $6 at Piper Sandler

    8/15/2023 - 09:28am
  • OncoCyte reports Q2 EPS ($1.03), consensus (87c)

    8/10/2023 - 07:46am
dynamic_feed Breaking News